Skip to main content
. 2021 Nov 5;18(11):1058–1067. doi: 10.30773/pi.2021.0169

Table 4.

Correlation between treatment decision-making in case vignettes and PAP scores

Attitudes in case vignette (1=not at all, 5=extremely) Correlation with PAP score (rho/p)
[A-1] How likely are you to increase his regular dose of risperidone? 0.0885
0.1044
[A-2] How likely are you to increase his regular dose of aripiprazole? 0.0832
0.1270
[A-3] How likely are you to add electroconvulsive therapy to his medication? -0.0349
0.5222
[A-4] How likely are you to add a new antipsychotic drug to his present medication? 0.2822***
<0.0001
[A-5] How likely are you to reduce the dose of his present medication and combine a new antipsychotic drug? 0.0778
0.1535
[A-6] How likely are you to replace all the present medications with new antipsychotics at a similar dose? -0.0270
0.6212
[B-1] How likely are you to agree with the additional risperidone (4 mg/day)? 0.2141***
0.0001
[B-2] How likely are you to agree with the additional chlorpromazine (50 mg/day)? 0.1805***
0.0009
[B-3] How likely are you to think that this three-type-combined medication is too much? -0.2938***
<0.0001

Significance levels of p<0.001 are indicated by ***. PAP, Psychiatrists’ attitudes toward polypharmacy